Roland von Känel1, Robert M Carney, Shoujun Zhao, Mary A Whooley. 1. Department of General Internal Medicine, Division of Psychosomatic Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. roland.vonkaenel@insel.ch
Abstract
BACKGROUND: Chronic low-grade systemic inflammation is a key component in atherogenesis. Decreased heart rate variability (HRV), a strong predictor of cardiovascular events, has been associated with elevations in circulating levels of C-reactive protein (CRP), interleukin (IL)-6, and fibrinogen in apparently healthy individuals. We investigated whether decreased HRV is associated with inflammatory markers in patients with coronary heart disease (CHD). METHODS: We studied the relationship between HRV and CRP, IL-6, and fibrinogen in 862 outpatients with CHD. All participants provided fasting blood samples and underwent 24-h ambulatory monitoring to assess time-domain measures of HRV (MeanNN, SDNN, SDANN, and RMSSD). Regression analyses were adjusted for age, sex, ethnicity, body mass index, smoking, diabetes, beta blocker use, and cardiopulmonary history. RESULTS: MeanNN, SDNN, and SDANN were significantly and inversely associated with CRP and IL-6 levels in age-adjusted models and after adjustment for all covariates (p ≤ 0.02). MeanNN, SDNN, and SDANN were also inversely associated with fibrinogen levels in age-adjusted models (p < 0.03), but not significantly so in multivariable-adjusted models. Reduced vagal modulation of heart rate (RMSSD) was not significantly associated with any inflammatory measures. CONCLUSIONS: Reduced cardiac autonomic control is associated with increased systemic inflammation in patients with stable CHD. This relationship was largely independent of important covariates.
BACKGROUND: Chronic low-grade systemic inflammation is a key component in atherogenesis. Decreased heart rate variability (HRV), a strong predictor of cardiovascular events, has been associated with elevations in circulating levels of C-reactive protein (CRP), interleukin (IL)-6, and fibrinogen in apparently healthy individuals. We investigated whether decreased HRV is associated with inflammatory markers in patients with coronary heart disease (CHD). METHODS: We studied the relationship between HRV and CRP, IL-6, and fibrinogen in 862 outpatients with CHD. All participants provided fasting blood samples and underwent 24-h ambulatory monitoring to assess time-domain measures of HRV (MeanNN, SDNN, SDANN, and RMSSD). Regression analyses were adjusted for age, sex, ethnicity, body mass index, smoking, diabetes, beta blocker use, and cardiopulmonary history. RESULTS: MeanNN, SDNN, and SDANN were significantly and inversely associated with CRP and IL-6 levels in age-adjusted models and after adjustment for all covariates (p ≤ 0.02). MeanNN, SDNN, and SDANN were also inversely associated with fibrinogen levels in age-adjusted models (p < 0.03), but not significantly so in multivariable-adjusted models. Reduced vagal modulation of heart rate (RMSSD) was not significantly associated with any inflammatory measures. CONCLUSIONS: Reduced cardiac autonomic control is associated with increased systemic inflammation in patients with stable CHD. This relationship was largely independent of important covariates.
Authors: John Danesh; Jeremy G Wheeler; Gideon M Hirschfield; Shinichi Eda; Gudny Eiriksdottir; Ann Rumley; Gordon D O Lowe; Mark B Pepys; Vilmundur Gudnason Journal: N Engl J Med Date: 2004-04-01 Impact factor: 91.245
Authors: Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley Journal: JAMA Date: 2003-07-09 Impact factor: 56.272
Authors: Richard P Sloan; Heather McCreath; Kevin J Tracey; Stephen Sidney; Kiang Liu; Teresa Seeman Journal: Mol Med Date: 2007 Mar-Apr Impact factor: 6.354
Authors: Marianne Debrunner; Ernst Schuiki; Elisabeth Minder; Edwin Straumann; Barbara Naegeli; Raymond Mury; Osmund Bertel; Jürgen Frielingsdorf Journal: Clin Res Cardiol Date: 2007-12-28 Impact factor: 5.460
Authors: Robert B Nichols; William F McIntyre; Salina Chan; David Scogstad-Stubbs; Wilma M Hopman; Adrian Baranchuk Journal: Clin Res Cardiol Date: 2011-09-09 Impact factor: 5.460
Authors: Roland Prondzinsky; Susanne Unverzagt; Henning Lemm; Nikolas-Arne Wegener; Axel Schlitt; Konstantin M Heinroth; Sebastian Dietz; Ute Buerke; Patrick Kellner; Harald Loppnow; Martin G Fiedler; Joachim Thiery; Karl Werdan; Michael Buerke Journal: Clin Res Cardiol Date: 2012-01-03 Impact factor: 5.460
Authors: Lari C Young; Mollie P Roediger; Greg Grandits; Jason Baker; Charurut Somboonwit; Ian Williams; Jens D Lundgren; James D Neaton; Elsayed Z Soliman Journal: Biomark Med Date: 2014 Impact factor: 2.851
Authors: L Breda; D Di Marzio; C Giannini; S Gaspari; M Nozzi; A Scarinci; F Chiarelli; A Mohn Journal: Clin Res Cardiol Date: 2012-08-11 Impact factor: 5.460